Royal Fund Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$843K Sell
9,775
-20,152
-67% -$1.78M 0.07% 201
2026
Q2
$2.34M Buy
29,927
+4,100
+16% +$331K 0.2% 134
2026
Q1
$2.24M Sell
25,827
-700
-3% -$67.1K 0.21% 130
2025
Q4
$2.55M Sell
26,527
-500
-2% -$48.6K 0.23% 122
2025
Q3
$2.57M Sell
27,027
-421
-2% -$38.7K 0.31% 102
2025
Q2
$2.39M Sell
27,448
-179
-0.6% -$15.2K 0.24% 132
2025
Q1
$2.48M Buy
+27,627
New +$2.47M 0.28% 121
2020
Q2
– Sell
-145
Closed -$13K – 387
2020
Q1
$13K Sell
145
-10
-6% -$1.06K 0.01% 349
2019
Q4
$17K Sell
155
-20
-11% -$2.2K ﹤0.01% 361
2019
Q3
$18K Buy
175
+32
+22% +$3.34K 0.01% 344
2019
Q2
$13K Sell
143
-23
-14% -$2.1K ﹤0.01% 369
2019
Q1
$15K Buy
166
+12
+8% +$1.07K ﹤0.01% 332
2018
Q4
$14K Buy
154
+11
+8% +$1.03K 0.01% 310
2018
Q3
$14K Sell
143
-336
-70% -$31.1K ﹤0.01% 304
2018
Q2
$41K Buy
479
+213
+80% +$17.8K 0.01% 214
2018
Q1
$21K Buy
+266
New +$21.9K 0.01% 275
2017
Q3
– Sell
-74
Closed -$6K – 497
2017
Q2
$6K Buy
+74
New +$6.24K ﹤0.01% 298

Other funds holding MDT

Royal Fund Management's MDT Position: Q3 2026 in Review

Royal Fund Management reduced its Medtronic (MDT) stake by 67% in Q3 2026, selling an estimated $1.78M and leaving 9,775 shares worth $843K. The position accounts for 0.07% of the portfolio, ranked #201.

Royal Fund Management first reported a position in MDT in Q2 2017 and has held it in 17 quarters since. The position peaked at $2.57M in Q3 2025. 2,200 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Royal Fund Management held 9,775 shares of Medtronic worth $843K as of Q3 2026.
  • Royal Fund Management sold 20,152 Medtronic shares in Q3 2026, an estimated $1.78M.
  • Medtronic made up 0.07% of Royal Fund Management's portfolio in Q3 2026, its #201 holding.
  • Royal Fund Management first reported a position in Medtronic in Q2 2017 and has held it in 17 quarters since.
  • Royal Fund Management's Medtronic position peaked at $2.57M in Q3 2025.
  • 2,200 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Royal Fund Management's 13F filing for Q3 2026, filed 22 Oct 2026.